Scotland · NHS Scotland MSAN
Estradiol valerate/medroxyprogesterone acetate (Indivina®) 1mg/5mg tablets
MSAN(2023)24 · Level 2 · issued 19 Sep 2023
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Estradiol valerate/medroxyprogesterone acetate (Indivina®) 1mg/5mg tablets are out of stock | Out of stock | — |
| 1mg but a different progesterone component remain available and will be able to support | Available | — |
| 3. Estradiol valerate/medroxyprogesterone acetate (Indivina®) 1mg/2.5mg tablets remain available | Available | — |
| but cannot support uplift in demand. | Available — cannot support uplift | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.